SCHEMBL6496667

SCHEMBL6496667

CC(NC(=O)C1CCN(C(=O)/C=C/c2ccc(OC3CCCC3)c(Cl)c2Cl)CC1)C(=O)O

nearest known ligand 0.45

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ITGAL P20701 8/20 0.45
ITGB2 P05107 7/20 0.45
ICAM1 P05362 7/20 0.45
CAPN1 P07384 3/20 0.41
NPC1 O15118 4/20 0.39
RAB9A P51151 4/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
APOBEC3A P31941 1/20 0.38
APOBEC3G Q9HC16 1/20 0.38
PDE4B Q07343 1/20 0.37
KDM4E B2RXH2 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
ALDH1A1 P00352 1/20 0.36
POLB P06746 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6496671 1.00 ITGAL (0.45) ITGALITGB2ICAM1CAPN1NPC1
SCHEMBL8296904 1.00 ITGAL (0.45) ITGALITGB2ICAM1CAPN1NPC1
SCHEMBL6497929 0.92 ITGAL (0.45) ITGALITGB2ICAM1CAPN1NPC1
SCHEMBL6497927 0.92 ITGAL (0.45) ITGALITGB2ICAM1CAPN1NPC1
SCHEMBL6504723 0.89 ITGAL (0.54) ITGALITGB2ICAM1CAPN1NPC1
SCHEMBL6504728 0.89 ITGAL (0.54) ITGALITGB2ICAM1CAPN1NPC1
SCHEMBL6504517 0.86 ITGAL (0.48) ITGALITGB2ICAM1CAPN1NPC1
SCHEMBL6504520 0.86 ITGAL (0.48) ITGALITGB2ICAM1CAPN1NPC1
SCHEMBL8298731 0.86 ITGAL (0.48) ITGALITGB2ICAM1CAPN1NPC1
SCHEMBL6497470 0.85 ITGAL (0.45) ITGALITGB2ICAM1CAPN1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005016883-A2 ACRYLAMIDE DERIVATIVES AS VLA-1 INTEGRIN ANTAGONISTS AND USES THEREOF ICOS CORPORATION (US) 2005-02-24 WO claimed
WO-2005016883-A2 ACRYLAMIDE DERIVATIVES AS VLA-1 INTEGRIN ANTAGONISTS AND USES THEREOF ICOS CORPORATION (US) 2005-02-24 WO disclosed